Epidural Sacral Injection study: effect of volume and triamcinolone on chronic lumbosacral radiculopathy?

Not Applicable

Completed

• Conditions: umbosacral radiculopathySciatica; Musculoskeletal Diseases; Radiculopathy

• Registration Number: ISRCTN12574253
• Lead Sponsor: niversity Hospital of North Norway - Neurosurgery department

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05-18
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

Age: 20-60 years
Sex: Both
Symptoms: Sciatic pain >12 weeks
Objective: Radiculopathy L3-S1

Exclusion Criteria

1. Indication of acute back surgery at the time of inclusion
2. Previous back surgery
3. Previous epidural or nerve root injection for low back pain or sciatica
4. Red flags
5. Yellow flags
6. The patient must not have noticed an improvement in symptoms or certralisation of pain from leg to back for the previous two weeks before inclusion
7. Pregnancy
8. Anticlotting therapy with Warfarin
9. Ongoing treatment with Non-Steroidal Anti-Inflammatory Drug (NSAID)
10. Magnetic Resonance Imaging (MRI) findings showing lateral recess stenosis of osteogenic aetiology, tumor, bleeding, dural fistula, synovial cyst, dysraphia conditions

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oswestry Disability Index (ODI)

Secondary Outcome Measures

Name	Time	Method
1. European Quality of life measure (EQ5-D)<br>2. Fear-Avoidance Beliefs (FABQ)<br>3. Visual Analog Scale (VAS) back pain, leg pain, general health<br>4. Number of patients referred to all types of Back Surgery during follow-up